December 20, 2022
Webinar
New Jersey Intellectual Property Law Association (NJIPLA)
Finnegan partner David Weingarten will join a panel discussion on the patentability of chemical and pharmaceutical inventions at the New Jersey Intellectual Property Law Association’s webinar. Discussion content will also cover novelty, obviousness, sufficiency of disclosure, as well as differences between the U.S. and Europe. For more information, or to register, please see NJIPLA’s website.
Webinar
Inventive Step in Europe and the US: Comparing the UPC, EPO and National Approaches
July 8, 2026
Webinar
Federal Circuit IP Blog
July 8, 2026
Federal Circuit IP Blog
June 26, 2026
European IP Blog
UPC Central Division Revokes Patent Covering Covid-19 Treatment Remdesivir
8 June 2026
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.